<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Prognosis of mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) remains poor </plain></SENT>
<SENT sid="1" pm="."><plain>Patients who achieve a response to first line therapy usually relapse, and the probability of cure remains low </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="16856">Glutathione</z:chebi>-S-transferase <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> (GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e>) overexpression has been associated with <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> and <z:chebi fb="0" ids="48120">anthracycline</z:chebi> resistance </plain></SENT>
<SENT sid="3" pm="."><plain>GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> gene is located in 11q13 and is coamplified along with CCND1 gene in some human <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>EXPERIMENTAL DESIGN: We performed immunohistochemical analysis of GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> expression in 24 consecutive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e>, 12 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (FLs), and 69 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Cases were classified in three groups: high GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> expression (&gt; 50% of cells were stained), moderate (5 to 50% cells were stained), or absent (&lt; 5% cells were stained) </plain></SENT>
<SENT sid="6" pm="."><plain>GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> and CCND1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were also assessed by real-time reverse transcription-PCR analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> exhibit high GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> protein expression, compared with 29% of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e> and none of the FLs </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> expressed high levels of GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> and CCND1 <z:chebi fb="2" ids="33699">mRNAs</z:chebi> compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e> and FLs </plain></SENT>
<SENT sid="9" pm="."><plain>There was a strong relation between GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> and CCND1 <z:chebi fb="2" ids="33699">mRNAs</z:chebi> transcript levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> but not in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCLs</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, protein and <z:chebi fb="2" ids="33699">mRNA</z:chebi> GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> expression is high in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> compared with FL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Overexpression of CCND1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> is associated with a transcriptional up-regulation of the GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> gene </plain></SENT>
<SENT sid="12" pm="."><plain>Our results suggest that the <z:chebi fb="0" ids="16856">glutathione</z:chebi> system could play a role in drug resistance in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
</text></document>